Boston Scientific to buy Nalu Medical for $533 million; stock up

Boston Scientific

17/10/2025 15:26

** Shares of medical device maker Boston Scientific BSX.N rise 1.3% to $98.57 in morning trading

** Co says it will acquire remaining equity in Nalu Medical, a private medical device maker, for about $533 million in cash to expand its treatments for chronic pain

** BSX gains Nalu's neurostimulation device, designed to deliver targeted relief to adults living with chronic pain in areas such as the shoulder, lower back and knee, through peripheral nerve stimulation (PNS)

** RBC says deal aligns with BSX's capital allocation strategy and complements its existing interventional pain offerings, expanding its total addressable market; rates BSX "outperform"

** RBC says Nalu estimates U.S. PNS market at $250 mln, with potential to reach $2-4 bln a year

** Including sessions move, stock up ~10% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.pandey@thomsonreuters.com))